Page last updated: 2024-08-25

5-hydroxymethylcytosine and cyclin d1

5-hydroxymethylcytosine has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alberge, JB; Attal, M; Avet-Loiseau, H; Campion, L; Carell, T; Denié, S; Guérin-Charbonnel, C; Magrangeas, F; Minvielle, S; Moreau, P; Sérandour, AA; Wagner, M	1

Other Studies

1 other study(ies) available for 5-hydroxymethylcytosine and cyclin d1

Article	Year
DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma. Clinical epigenetics, 2020, 11-02, Volume: 12, Issue:1 Topics: 5-Methylcytosine; Chromatin; Cyclin D1; Cyclin D2; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Gene Expression Regulation, Neoplastic; Genome; Histone-Lysine N-Methyltransferase; Humans; Male; Middle Aged; Multiple Myeloma; Phenotype; Proto-Oncogene Proteins c-myc; Regulatory Sequences, Nucleic Acid; Repressor Proteins; Severity of Illness Index	2020

Article

Year

DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.

Clinical epigenetics, 2020, 11-02, Volume: 12, Issue:1

Topics: 5-Methylcytosine; Chromatin; Cyclin D1; Cyclin D2; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Gene Expression Regulation, Neoplastic; Genome; Histone-Lysine N-Methyltransferase; Humans; Male; Middle Aged; Multiple Myeloma; Phenotype; Proto-Oncogene Proteins c-myc; Regulatory Sequences, Nucleic Acid; Repressor Proteins; Severity of Illness Index

2020